Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Moreno Valley › NPI 1174793459
Hospital

Kaiser Foundation Hospitals

Kaiser Foundation Hospitals was paid $26.26M by Medicaid between Jan 2018 and Dec 2024, across 245 billing codes. Its largest line is 99283, emergency room visit (moderate) — 57% of everything it billed.

33Billing provider infoKAISER FOUNDATION HOSPITALS
MORENO VALLEY, CA 92555
33aNPI1174793459assigned 03/03/2008
33bProvider typeGeneral Acute Care Hospital
28Total paid$26.26M
24GClaims857,716
24DCodes billed245
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#100 of 410
Median peer was paid$6.90M
This provider vs. median3.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201877,480$966K
201976,620$323K
202077,344$2.30M
202192,217$3.56M
2022133,072$5.01M
2023157,911$5.47M
2024incomplete243,072$8.63M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 57% 52,135 46,933 $14.95M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.4% 7,129 6,689 $2.48M
99282 Emergency department visit for the evaluation and management, low to moderate severity 4.8% 6,057 5,820 $1.25M
G0378 Hospital observation service, per hour 3.8% 3,892 2,448 $986K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.2% 4,232 4,085 $852K
0450 Emergency room services 2.1% 10,811 9,937 $561K
70450 Computed tomography, head or brain; without contrast material 1.4% 6,002 5,764 $373K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.2% 3,348 3,225 $314K
71045 Radiologic examination, chest; single view 1.1% 10,387 9,707 $288K
99499 <1% 1,853 1,690 $234K
71046 Radiologic examination, chest; 2 views <1% 6,216 5,971 $218K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 12,366 11,989 $174K
233 more codes
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,816 $152K
80051 <1% 42,797 $151K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,424 $151K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,003 $141K
86885 <1% 2,752 $118K
70551 Magnetic resonance imaging, brain; without contrast material <1% 860 $112K
76830 Ultrasound, transvaginal <1% 1,777 $110K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 41,500 $102K
86900 <1% 4,482 $92K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 6,169 $77K
Z7502 <1% 2,368 $76K
76801 <1% 1,337 $75K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 9,341 $70K
82565 <1% 45,788 $69K
84702 <1% 12,512 $64K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 392 $58K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 187 $57K
77067 Screening mammography, bilateral, including computer-aided detection <1% 825 $55K
87088 <1% 9,593 $54K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 437 $53K
72125 Computed tomography, cervical spine; without contrast material <1% 688 $52K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 377 $49K
84460 <1% 27,462 $49K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,541 $48K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,543 $48K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 2,335 $42K
82247 <1% 24,896 $40K
84520 <1% 38,779 $40K
82947 <1% 35,023 $39K
96375 Therapeutic injection; each additional sequential IV push <1% 5,997 $37K
84484 <1% 17,385 $36K
84075 <1% 23,291 $36K
84450 <1% 21,833 $36K
74174 <1% 163 $36K
83880 <1% 6,813 $36K
73630 <1% 1,117 $35K
73562 <1% 993 $34K
83690 <1% 16,254 $34K
93971 <1% 759 $34K
71250 <1% 426 $32K
86901 <1% 4,480 $30K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,153 $29K
84443 Thyroid stimulating hormone (TSH) <1% 3,827 $28K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 235 $26K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 2,462 $25K
73610 <1% 829 $24K
81003 <1% 25,917 $23K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,102 $23K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 2,993 $22K
83036 Hemoglobin; glycosylated (A1C) <1% 6,244 $21K
74018 <1% 422 $21K
73030 <1% 622 $20K
J7030 Infusion, normal saline solution , 1000 cc <1% 15,884 $19K
85027 <1% 8,273 $19K
70496 <1% 111 $18K
82248 <1% 10,545 $18K
73130 <1% 656 $18K
80061 Lipid panel <1% 2,487 $17K
70498 <1% 107 $17K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,153 $16K
90686 <1% 1,759 $16K
83735 <1% 11,028 $16K
0637 <1% 60,566 $16K
82310 <1% 9,192 $13K
87040 <1% 7,153 $13K
87505 <1% 153 $13K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 811 $12K
85610 <1% 10,518 $12K
76770 <1% 181 $11K
70486 <1% 92 $11K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 839 $11K
72141 <1% 63 $11K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 697 $10K
93970 <1% 173 $10K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 95 $9K
73110 <1% 317 $9K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 60 $9K
86141 <1% 2,497 $9K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,982 $9K
82570 <1% 2,970 $9K
86780 <1% 967 $8K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 710 $8K
80076 <1% 1,467 $8K
83605 <1% 4,159 $8K
83970 <1% 474 $8K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 79 $7K
82728 <1% 1,119 $7K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 7,728 $7K
70491 <1% 39 $7K
96361 Intravenous infusion, hydration; each additional hour <1% 2,226 $7K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,062 $7K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 5,440 $6K
86803 <1% 612 $6K
76870 <1% 78 $6K
76881 <1% 61 $6K
85379 <1% 1,475 $6K
84156 <1% 2,765 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 815 $5K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,232 $5K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 519 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 8,788 $5K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 181 $5K
80306 <1% 825 $5K
73590 <1% 111 $5K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,345 $4K
87340 <1% 996 $4K
74022 <1% 162 $4K
A9585 Injection, gadobutrol, 0.1 ml <1% 148 $4K
0258 <1% 1,609 $4K
83615 <1% 1,172 $4K
84439 <1% 836 $4K
85730 <1% 2,517 $4K
0250 <1% 6,575 $4K
83550 <1% 963 $4K
84100 <1% 4,341 $4K
76536 <1% 55 $4K
82607 <1% 382 $3K
72131 <1% 45 $3K
87081 <1% 2,251 $3K
87497 <1% 101 $3K
90656 <1% 526 $3K
82077 <1% 1,191 $3K
83540 <1% 937 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,160 $3K
85652 <1% 2,119 $3K
82040 <1% 1,968 $2K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 265 $2K
81513 <1% 29 $2K
82043 <1% 917 $2K
82550 <1% 1,379 $2K
84132 <1% 1,349 $2K
86762 <1% 387 $2K
76380 <1% 26 $2K
87210 <1% 977 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 144 $2K
87449 <1% 208 $2K
73140 <1% 29 $2K
90688 <1% 102 $2K
82950 <1% 466 $2K
82746 <1% 193 $2K
86787 <1% 388 $2K
80179 <1% 592 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,959 $1K
87481 <1% 44 $1K
82962 <1% 1,631 $1K
86765 <1% 123 $1K
86923 <1% 17 $1K
82105 <1% 115 $1K
73090 <1% 51 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,029 $1K
73080 <1% 61 $1K
83520 <1% 236 $1K
J3490 Unclassified drugs <1% 2,883 $1K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 29 $1K
86364 <1% 105 $1K
82805 <1% 61 $1K
84550 <1% 451 $973.13
73502 <1% 42 $956.21
0710 <1% 314 $950.37
80197 <1% 88 $839.69
87186 <1% 768 $748.10
J1815 Injection, insulin, per 5 units <1% 1,755 $733.48
86704 <1% 88 $624.99
86317 <1% 59 $616.00
81015 <1% 286 $584.62
96367 <1% 100 $510.04
84165 <1% 137 $502.00
87631 <1% 111 $494.87
P9021 Red blood cells, each unit <1% 15 $466.01
83001 <1% 29 $465.00
J1170 Injection, hydromorphone, up to 4 mg <1% 761 $449.19
87205 <1% 273 $445.32
87324 <1% 57 $439.88
G0008 Administration of influenza virus vaccine <1% 1,146 $432.89
84146 <1% 28 $425.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 305 $406.65
0370 <1% 313 $396.90
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 557 $383.43
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 829 $381.84
84403 <1% 25 $372.00
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 54 $354.24
90662 <1% 189 $338.49
72100 <1% 24 $333.60
97161 <1% 213 $315.11
J1650 Injection, enoxaparin sodium, 10 mg <1% 687 $285.24
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 43 $281.38
84153 <1% 39 $255.00
A0429 Emergency ambulance ride, basic life support <1% 23 $248.00
86140 <1% 65 $226.57
82951 <1% 14 $220.00
J3475 Injection, magnesium sulfate, per 500 mg <1% 583 $212.37
86038 <1% 28 $210.00
84295 <1% 74 $202.72
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 366 $200.32
86308 <1% 104 $192.49
J2060 Injection, lorazepam, 2 mg <1% 308 $191.54
82784 <1% 14 $189.34
83021 <1% 121 $187.09
J1836 Injection, metronidazole, 10 mg <1% 125 $144.16
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 13 $112.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 512 $104.39
J2470 Injection, pantoprazole sodium, 40 mg <1% 158 $101.82
83721 <1% 31 $99.00
80048 Basic metabolic panel (calcium, ionized) <1% 13 $86.40
J0690 Injection, cefazolin sodium, 500 mg <1% 161 $81.94
J3480 Injection, potassium chloride, per 2 meq <1% 378 $80.96
J0360 Injection, hydralazine hcl, up to 20 mg <1% 111 $71.30
80053 Comprehensive metabolic panel <1% 12 $70.10
82952 <1% 14 $70.00
J1644 Injection, heparin sodium, per 1000 units <1% 592 $68.35
87807 <1% 55 $67.54
J1940 Injection, furosemide, up to 20 mg <1% 535 $66.41
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 19 $66.10
J0737 Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg <1% 14 $55.42
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 55 $46.67
J0456 Injection, azithromycin, 500 mg <1% 266 $46.26
J0780 Injection, prochlorperazine, up to 10 mg <1% 35 $45.45
84155 <1% 15 $35.00
87149 <1% 28 $32.48
J1171 Injection, hydromorphone, 0.1 mg <1% 49 $28.42
C9113 Injection, pantoprazole sodium, per vial <1% 189 $25.39
J7510 Prednisolone oral, per 5 mg <1% 117 $23.79
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 43 $20.68
J3010 Injection, fentanyl citrate, 0.1 mg <1% 163 $15.18
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 29 $7.70
85014 <1% 25 $1.72
84145 0% 14 $0.00
92610 0% 30 $0.00
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 0% 38 $0.00
90749 0% 26 $0.00
99238 Hospital discharge day management, 30 minutes or less 0% 18 $0.00
3044F 0% 95 $0.00
88305 Level IV - Surgical pathology, gross and microscopic examination 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLETT, VITA (EXECUTIVE DIRECTOR)
Same official

Other billing entities under WILLETT, VITA

Full network →
ProviderLocationPaid
Kaiser Foundation HospitalsRiverside, CA$60.33M
Kaiser Foundation HospitalsMoreno Valley, CA$115K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.